| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |